Literature DB >> 22588789

ADHD in adults: a concept in evolution.

Breno Matte1, Luis Augusto Rohde, Eugenio Horácio Grevet.   

Abstract

Although attention-deficit/hyperactivity disorder (ADHD) has been recognized as a disorder affecting individuals across the life cycle since the end of the nineties, there is still considerable debate on how to conceptualize the disorder in adults, and on the best way to operationalize diagnostic criteria for this age range. In this comprehensive non-systematic review of the literature, we provide data about prevalence and presentation of ADHD in adulthood as well as discuss major problems in applying criteria developed for children in assessing adults (clinical utility, threshold of symptoms for diagnosis, full ADHD diagnosis in childhood, information source, and additional dimensions for diagnosis-executive functioning impairment and emotional impulsivity). In addition, we provide some recommendations for improving ADHD diagnostic criteria in adulthood.

Entities:  

Mesh:

Year:  2012        PMID: 22588789     DOI: 10.1007/s12402-012-0077-3

Source DB:  PubMed          Journal:  Atten Defic Hyperact Disord        ISSN: 1866-6116


  9 in total

1.  'Do I need to become someone else?' A qualitative exploratory study into the experiences and needs of adults with ADHD.

Authors:  Samuel J C Schrevel; Christine Dedding; Jeroen A van Aken; Jacqueline E W Broerse
Journal:  Health Expect       Date:  2015-01-05       Impact factor: 3.377

2.  Attention-Deficit/Hyperactivity Disorder (ADHD) and Time Perception in Adults: Do Adults with Different ADHD Symptomatology Severity Perceive Time Differently? Findings from the National Czech Study.

Authors:  Radek Ptáček; Martina Vňuková; Filip Děchtěrenko; Simon Weissenberger; Eva Kitzlerová; Hana Ptáčková; Martin Anders
Journal:  Med Sci Monit       Date:  2022-07-16

3.  Adult attention-deficit hyperactivity disorder and obesity: epidemiological study.

Authors:  Samuele Cortese; Stephen V Faraone; Silvia Bernardi; Shuai Wang; Carlos Blanco
Journal:  Br J Psychiatry       Date:  2013-05-09       Impact factor: 9.319

4.  Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study.

Authors:  Terrie E Moffitt; Renate Houts; Philip Asherson; Daniel W Belsky; David L Corcoran; Maggie Hammerle; HonaLee Harrington; Sean Hogan; Madeline H Meier; Guilherme V Polanczyk; Richie Poulton; Sandhya Ramrakha; Karen Sugden; Benjamin Williams; Luis Augusto Rohde; Avshalom Caspi
Journal:  Am J Psychiatry       Date:  2015-05-22       Impact factor: 18.112

5.  ADHD in DSM-5: a field trial in a large, representative sample of 18- to 19-year-old adults.

Authors:  B Matte; L Anselmi; G A Salum; C Kieling; H Gonçalves; A Menezes; E H Grevet; L A Rohde
Journal:  Psychol Med       Date:  2014-06-23       Impact factor: 7.723

6.  Clozapine-Induced Late Agranulocytosis and Severe Neutropenia Complicated with Streptococcus pneumonia, Venous Thromboembolism, and Allergic Vasculitis in Treatment-Resistant Female Psychosis.

Authors:  Christina Voulgari; Raphael Giannas; Georgios Paterakis; Anna Kanellou; Nikolaos Anagnostopoulos; Stamata Pagoni
Journal:  Case Rep Med       Date:  2015-02-10

7.  Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.

Authors:  Øystein Karlstad; Helga Zoëga; Kari Furu; Shahram Bahmanyar; Jaana E Martikainen; Helle Kieler; Anton Pottegård
Journal:  Eur J Clin Pharmacol       Date:  2016-09-01       Impact factor: 2.953

Review 8.  Developmental trauma disorder: pros and cons of including formal criteria in the psychiatric diagnostic systems.

Authors:  Marc Schmid; Franz Petermann; Joerg M Fegert
Journal:  BMC Psychiatry       Date:  2013-01-03       Impact factor: 3.630

9.  Psychiatric comorbidity distribution and diversities in children and adolescents with attention deficit/hyperactivity disorder: a study from Turkey.

Authors:  Murat Yüce; Süleyman Salih Zoroglu; Mehmet Fatih Ceylan; Hasan Kandemir; Koray Karabekiroglu
Journal:  Neuropsychiatr Dis Treat       Date:  2013-11-14       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.